---
category: news
title: "Remdesivir helps coronavirus patients — but at what cost?"
excerpt: "Gilead has rocketed into the public consciousness with one of the most promising coronavirus treatments, but the company’s history of sky high drug pricing is drawing increasing scrutiny from Congress about how much it will charge for remdesivir and who will get access."
publishedDateTime: 2020-05-06T17:48:00Z
webUrl: "https://www.politico.com/news/2020/05/06/remdesivir-helps-coronavirus-patients-but-at-what-cost-240230"
ampWebUrl: "https://www.politico.com/amp/news/2020/05/06/remdesivir-helps-coronavirus-patients-but-at-what-cost-240230"
cdnAmpWebUrl: "https://www-politico-com.cdn.ampproject.org/c/s/www.politico.com/amp/news/2020/05/06/remdesivir-helps-coronavirus-patients-but-at-what-cost-240230"
type: article
quality: 115
heat: 115
published: true

provider:
  name: Politico
  domain: politico.com

topics:
  - Treatment
  - Coronavirus
  - Political Impact

images:
  - url: "https://static.politico.com/cb/5a/2c1a7a5c4545bcecf70f3ebd5396/gettyimages-1221879711.jpg"
    width: 1160
    height: 773
    title: "Remdesivir helps coronavirus patients — but at what cost?"

secured: "nayFSgT5MoYRgDi9AQeX1V9yKRKIhJUZQaQo4HMsKzlVwjW9jZ/p6s+9fEqQUXepudKztDTgw5bSPJHynY8aqVLO1bZBtyb0IhZbuAMuziGeZs992jfRV0e2Usa2HxAiT2EOnMHKa6LQNf1UcWSTvMCW6gJtIwpbbTCy9R5JC3BHwtC6EAonfNuSL7RjbI0tbknvp9kjJ/eIv/lATKpcXgQc6AiKsd2SY3DXHCnAzaqHShM8fuAVuPPDhyUmQzsz1PL++vpg2NGsVI7wijWIN1PJf6Fqp9zqHmCKNmhro+/R7NEXo2/VcvhOe81LkTW7;pEiAJxVvrA/WFLRNcvaipw=="
---

